About: Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study)
Creator	Hutchinson, Peter Jenkinson, Michael Afshari, Fardad Albanese, Erminia Barua, Neil Bulbeck, Helen Chan, Huan Critchley, Giles Flannery, Thomas Fountain, Daniel Joannides, Alexis Mathew, Ryan Piper, Rory Plaha, Puneet Poon, Michael Price, Stephen Rajaraman, Chittoor Rominiyi, Ola Smith, Stuart Solomou, Georgios Solth, Anna Surash, Surash Watts, Colin Wykes, Victoria
source	Medline; PMC
abstract	OBJECTIVES: Pressures on healthcare systems due to COVID-19 has impacted patients without COVID-19 with surgery disproportionally affected. This study aims to understand the impact on the initial management of patients with brain tumours by measuring changes to normal multidisciplinary team (MDT) decision making. DESIGN: A prospective survey performed in UK neurosurgical units performed from 23 March 2020 until 24 April 2020. SETTING: Regional neurosurgical units outside London (as the pandemic was more advanced at time of study). PARTICIPANTS: Representatives from all units were invited to collect data on new patients discussed at their MDT meetings during the study period. Each unit decided if management decision for each patient had changed due to COVID-19. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome measures included number of patients where the decision to undergo surgery changed compared with standard management usually offered by that MDT. Secondary outcome measures included changes in surgical extent, numbers referred to MDT, number of patients denied surgery not receiving any treatment and reasons for any variation across the UK. RESULTS: 18 units (75%) provided information from 80 MDT meetings that discussed 1221 patients. 10.7% of patients had their management changed—the majority (68%) did not undergo surgery and more than half of this group not undergoing surgery had no active treatment. There was marked variation across the UK (0%–28% change in management). Units that did not change management could maintain capacity with dedicated oncology lists. Low volume units were less affected. CONCLUSION: COVID-19 has had an impact on patients requiring surgery for malignant brain tumours, with patients receiving different treatments—most commonly not receiving surgery or any treatment at all. The variations show dedicated cancer operating lists may mitigate these pressures. STUDY REGISTRATION: This study was registered with the Royal College of Surgeons of England’s COVID-19 Research Group (https://www.rcseng.ac.uk/coronavirus/rcs-covid-research-group/).
has issue date	2020-08-16(xsd:dateTime)
bibo:doi	10.1136/bmjopen-2020-040898
bibo:pmid	32801210
has license	cc-by
sha1sum (hex)	e6d65664c7009798e481e2fb4e097de9404cb75e
schema:url	https://doi.org/10.1136/bmjopen-2020-040898
resource representing a document's title	Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study)
has PubMed Central identifier	PMC7430412
has PubMed identifier	32801210
schema:publication	BMJ Open
resource representing a document's body	covid:e6d65664c7009798e481e2fb4e097de9404cb75e#body_text
is schema:about of	named entity 'radiology' named entity 'gliomas' named entity 'firstline' named entity 'decision making' named entity 'oncology' named entity 'Microsoft Excel' named entity 'Funnel plot' named entity 'tumour' named entity 'decision making' named entity 'COVID-19' named entity 'COVID-19' named entity 'tumour' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'neurosurgical' named entity 'video conferencing' named entity 'Kolmogorov-Smirnov test' named entity 'chemotherapy' named entity 'biopsy' named entity 'metastatic' named entity 'neurosurgical' named entity 'biopsies' named entity 'MDT' named entity 'neurosurgery' named entity 'London' named entity 'MDT' named entity 'brain tumours' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'MDT' named entity 'brain tumour' named entity 'tumour' named entity 'prognostic factor' named entity 'MDT' named entity 'glioma' named entity 'London' named entity 'brain tumours' named entity 'COVID-19' named entity 'patient care' named entity 'brain tumours' named entity 'COVID-19 pandemic' named entity 'oncology' named entity 'quality of life' named entity 'primary outcome measure' named entity 'surgical resection' named entity 'oncology' named entity 'COVID-19' named entity 'MDT' named entity 'MDT' named entity 'COVID-19' named entity 'MDT' named entity 'cancer surgery' named entity 'MDT' named entity 'decision making' named entity 'South West' named entity 'tumour' named entity 'neurosurgical' named entity 'MDT'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software